We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$117M
AUM Growth
+$2.04M
Cap. Flow
-$881K
Cap. Flow %
-0.76%
Top 10 Hldgs %
18.19%
Holding
211
New
44
Increased
43
Reduced
69
Closed
42

Sector Composition

Rank Sector Weight
1 Industrials 21.2%
2 Healthcare 17.54%
3 Technology 13.08%
4 Financials 12.18%
5 Consumer Staples 10.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$618B
$2.98M 2.56%
28,504
-350
-1% -$36.9K
CHD icon
2
Church & Dwight Co
CHD
$23.4B
$2.79M 2.39%
70,700
-2,500
-3% -$92.3K
XOM icon
3
ExxonMobil
XOM
$644B
$2.57M 2.2%
27,803
+462
+2% +$43.1K
QCOM icon
4
Qualcomm
QCOM
$155B
$2.48M 2.13%
33,390
+5,275
+19% +$386K
GE icon
5
GE Aerospace
GE
$374B
$2.13M 1.82%
17,560
+915
+5% +$113K
IHG icon
6
InterContinental Hotels
IHG
$23.9B
$1.94M 1.66%
36,733
+3,208
+10% +$164K
AB icon
7
AllianceBernstein
AB
$3.43B
$1.76M 1.51%
68,211
+32,306
+90% +$828K
INDB icon
8
Independent Bank
INDB
$3.99B
$1.75M 1.5%
40,947
-1,700
-4% -$67.3K
EMR icon
9
Emerson Electric
EMR
$83.9B
$1.41M 1.21%
22,871
-225
-1% -$14.1K
CNI icon
10
Canadian National Railway
CNI
$76.9B
$1.4M 1.2%
20,300
-800
-4% -$54.7K
PRXL
11
DELISTED
Parexel International Corp
PRXL
$1.35M 1.15%
24,225
+19,350
+397% +$1.12M
AVT icon
12
Avnet
AVT
$7.29B
$1.31M 1.13%
30,525
+3,025
+11% +$128K
TFC icon
13
Truist Financial
TFC
$63.3B
$1.26M 1.09%
32,515
UPS icon
14
United Parcel Service
UPS
$88.6B
$1.26M 1.08%
11,295
+875
+8% +$92.3K
CELG
15
DELISTED
Celgene Corp
CELG
$1.24M 1.07%
11,125
-2,305
-17% -$243K
FAST icon
16
Fastenal
FAST
$54.7B
$1.23M 1.05%
103,396
-24,800
-19% -$278K
DD icon
17
DuPont de Nemours
DD
$18.5B
$1.22M 1.05%
+10,583
New +$1.29M
AMGN icon
18
Amgen
AMGN
$208B
$1.19M 1.02%
7,475
-1,750
-19% -$273K
KMB icon
19
Kimberly-Clark
KMB
$36.3B
$1.19M 1.02%
10,253
-441
-4% -$48.9K
MRK icon
20
Merck
MRK
$322B
$1.17M 1.01%
21,660
+1,396
+7% +$77.8K
TKR icon
21
Timken Company
TKR
$9.56B
$1.16M 0.99%
27,055
+1,425
+6% +$59.9K
PFE icon
22
Pfizer
PFE
$143B
$1.12M 0.96%
38,034
+5,007
+15% +$144K
GSK icon
23
GSK
GSK
$104B
$1.11M 0.95%
20,696
+1,640
+9% +$91.8K
PG icon
24
Procter & Gamble
PG
$336B
$1.1M 0.94%
12,030
TAP icon
25
Molson Coors Class B
TAP
$7.79B
$1.07M 0.91%
+14,300
New +$1.06M

Similar funds

New England Research & Management's Q4 2014 Portfolio in Review

As of Q4 2014, New England Research & Management held 211 positions worth $117M, up 1.8% from $115M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

New England Research & Management's Q4 2014 filing shows 44 new, 43 increased, 69 reduced and 42 closed positions. Its largest new stake was DuPont de Nemours: 10,583 shares worth $1.22M. The largest sale was KINDER MORGAN ENER PNTRS L.P., an estimated $1.07M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, down from 25% a quarter earlier, followed by Healthcare and Technology.

  • New England Research & Management's largest Q4 2014 buy was DuPont de Nemours: 10,583 shares worth $1.22M.
  • New England Research & Management added most to Parexel International Corp in Q4 2014, an estimated $1.12M increase.
  • New England Research & Management's biggest Q4 2014 reduction was Occidental Petroleum, cutting an estimated $925K.
  • New England Research & Management fully exited KINDER MORGAN ENER PNTRS L.P. in Q4 2014, selling an estimated $1.07M.
  • New England Research & Management's ten largest holdings make up 18% of its $117M portfolio in Q4 2014.
  • New England Research & Management opened 44 new positions and closed 42 in Q4 2014.
  • New England Research & Management's portfolio value rose 1.8% quarter-over-quarter to $117M.

Based on New England Research & Management's 13F filing for Q4 2014, filed 21 Jan 2015.